A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants

Clinical trial NCT07108894 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07108894
Sponsor: AbCellera Biologics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-07-25
Primary completion: 2027-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.